When treating COPD with inhaled corticosteroids, what potential side effect should be monitored?

When treating Chronic Obstructive Pulmonary Disease (COPD) with inhaled corticosteroids, it is important to monitor for increased bruising. This side effect can occur due to the systemic absorption of corticosteroids, even when using inhaled forms, especially with long-term use. Inhaled corticosteroids can lead to skin thinning and decrease the skin’s ability to withstand minor trauma, which can result in increased bruising.

Monitoring for this side effect is crucial, as it indicates that the medication may be affecting the patient’s skin integrity. Healthcare providers often assess patients' skin condition as part of routine check-ups when prescribing inhaled corticosteroids to ensure that the benefits of the medication continue to outweigh any potential risks or side effects. While other side effects could potentially be associated with different types of medications or conditions, increased bruising is specifically linked to the use of inhaled corticosteroids, making it a key effect to monitor in this context.